Almonty Industries Inc. (ETR:ALI1)

Oncternal Therapeutics Revenue

Almonty Industries had revenue of 7.91M CAD in the quarter ending March 31, 2025, with 1.07% growth. This brings the company's revenue in the last twelve months to 28.92M, up 24.46% year-over-year. In the year 2024, Almonty Industries had annual revenue of 28.84M with 28.10% growth.

• Revenue (ttm): 28.92M CAD
• Revenue Growth: +24.46%
• P/S Ratio: 38.37
• Revenue / Employee: 71.76K CAD
• Employees: 403
• Market Cap: 714.32M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.84M	6.33M	28.10%
Dec 31, 2023	22.51M	-2.29M	-9.22%
Dec 31, 2022	24.80M	3.95M	18.94%
Dec 31, 2021	20.85M	-4.25M	-16.93%
Dec 31, 2020	25.10M	-13.13M	-34.34%